Inhibition of cholesterol absorption by SCH 58053 in the mouse is not mediated via changes in the expression of mRNA for ABCA1, ABCG5, or ABCG8 in the enterocyte

被引:68
作者
Repa, JJ
Dietschy, JM
Turley, SD [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA
[2] Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA
关键词
liver; small intestine; bile acid; cholesterol efflux; cholesterol synthesis; fecal neutral sterol;
D O I
10.1194/jlr.M200144-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Intestinal cholesterol absorption is a major determinant of plasma low density lipoprotein-cholesterol (LDL-C) concentrations. Ezetimibe (SCH 58235) and its analogs SCH 48461 and SCH 58053 are novel potent inhibitors of cholesterol absorption whose mechanism of action is unknown. These studies investigated the effect of SCH 58053 on cholesterol metabolism in female 129/Sv mice. In mice fed a low cholesterol rodent diet containing SCH 58053, cholesterol absorption was reduced by 46% and fecal neutral sterol excretion was increased 67%, but biliary lipid composition and bile acid synthesis, pool size, and pool composition were unchanged. When the dietary cholesterol content was increased either 10- or 50-fold, those animals given SCH 58053 manifested lower hepatic and biliary cholesterol concentrations than did their untreated controls. Cholesterol feeding increased the relative mRNA level for adenosine triphosphate-binding cassette transporter A1 (ABCA1), ABC transporter G5 (ABCG5), and ABC transporter G8 (ABCG8) in the jejunum, and of ABCG5 and ABCG8 in the liver, but the magnitude of this increase was generally less if the mice were given SCH 58053. We conclude that the inhibition of cholesterol absorption effected by this new class of agents is not mediated via changes in either the size or composition of the intestinal bile acid pool, or the level of mRNA expression of proteins that facilitate cholesterol efflux from the enterocyte, but rather may involve disruption of the uptake of luminal sterol across the microvillus membrane.
引用
收藏
页码:1864 / 1874
页数:11
相关论文
共 58 条
[1]   The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption [J].
Altmann, SW ;
Davis, HR ;
Yao, XR ;
Laverty, M ;
Compton, DS ;
Zhu, LJ ;
Crona, JH ;
Caplen, MA ;
Hoos, LM ;
Tetzloff, G ;
Priestley, T ;
Burnett, DA ;
Strader, CD ;
Graziano, MP .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2002, 1580 (01) :77-93
[2]   Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: Pooled analysis of two phase II studies [J].
Bays, HE ;
Moore, PB ;
Drehobl, MA ;
Rosenblatt, S ;
Toth, PD ;
Dujovne, CA ;
Knopp, RH ;
Lipka, LJ ;
LeBeaut, AP ;
Yang, B ;
Mellars, LE ;
Cuffie-Jackson, C ;
Veltri, EP .
CLINICAL THERAPEUTICS, 2001, 23 (08) :1209-1230
[3]   SEX-DIFFERENCES IN SIZE OF BILE-ACID POOLS [J].
BENNION, LJ ;
DROBNY, E ;
KNOWLER, WC ;
GINSBERG, RL ;
GARNICK, MB ;
ADLER, RD ;
DUANE, WC .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1978, 27 (08) :961-969
[4]   Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters [J].
Berge, KE ;
Tian, H ;
Graf, GA ;
Yu, LQ ;
Grishin, NV ;
Schultz, J ;
Kwiterovich, P ;
Shan, B ;
Barnes, R ;
Hobbs, HH .
SCIENCE, 2000, 290 (5497) :1771-1775
[5]  
BHATTACHARYYA AK, 1980, J LIPID RES, V21, P518
[6]  
Bosner MS, 1999, J LIPID RES, V40, P302
[7]   Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice [J].
Buhman, KK ;
Accad, M ;
Novak, S ;
Choi, RS ;
Wong, JS ;
Hamilton, RL ;
Turley, S ;
Farese, RV .
NATURE MEDICINE, 2000, 6 (12) :1341-1347
[8]   Genetic variation in cholesterol absorption efficiency among inbred strains of mice [J].
Carter, CP ;
Howles, PN ;
Hui, DY .
JOURNAL OF NUTRITION, 1997, 127 (07) :1344-1348
[9]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[10]   EFFECTS OF SUCROSE POLYESTER ON CHOLESTEROL-METABOLISM IN MAN [J].
CROUSE, JR ;
GRUNDY, SM .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1979, 28 (10) :994-1000